ArticleDrug design, development and therapy2026
Effect of Liposomal Bupivacaine for Fascia Iliaca Compartment Block on Early Postoperative Recovery Quality in Elderly Patients Undergoing Total Hip Arthroplasty: A Retrospective Cohort Study.
Article in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Liposomal Bupivacaine in Perioperative Analgesia: A Comprehensive Review of Clinical Efficacy, Safety, and Economic Context.Current pain and headache reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This retrospective cohort study aimed to determine whether liposomal bupivacaine used in suprainguinal fascia iliaca compartment block (S-FICB) is superior to 0.33% ropivacaine in improving the quality of early postoperative recovery in elderly patients with hip fractures who underwent total hip arthroplasty (THA). Outcomes included: 15-item Quality of Recovery Scale (QoR-15); Numerical Rating Scale (NRS) for pain; Pittsburgh Sleep Quality Index (PSQI); Harris Hip Score; plus rescue analgesic use and hospital stay. It should be noted that the observed benefits are limited to the early postoperative period. Methods: A retrospective analysis was conducted on 200 elderly patients (aged 65-85 years) with hip fractures who underwent total hip arthroplasty (THA). Patients were divided into two groups based on the local anesthetic they received for S-FICB: the ropivacaine group (RG group, n = 100) or the liposomal bupivacaine group (LBG group, n = 100). QoR-15 and Harris scores were recorded preoperatively and on days 1, 3, 5 postoperatively. NRS and PSQI were recorded preoperatively and on days 1, 2, 3, 5. Rescue analgesic consumption and hospital stay were recorded. Results: On postoperative day 1, QoR-15 was higher in LBG vs RG (113.25±3.825 vs 105.6±3.75, P=0.0004). NRS was lower in LBG within the first 48 postoperative hours (P < 0.05). PSQI was better in LBG on postoperative days 1 and 2 (P < 0.01). Harris score was higher in LBG on postoperative day 1 (P = 0.0007). Rescue analgesic use and postoperative hospital stay were lower in LBG (P < 0.05). Conclusion: Liposomal bupivacaine is superior to ropivacaine in the early postoperative recovery and analgesia of elderly THA patients. However, this advantage is primarily limited to the early postoperative period. Prospective validation is required given the retrospective design.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.